High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with early steroid withdrawal and calcineurin inhibitor-free maintenance therapy in renal transplantation: Experiences of a randomized prospective single-center study

Transplantation Proceedings

Volumn 44, Issue 10, 2012, Pages 2961-2965

  Burkhalter, F ^a   Oettl, T ^a   Descoeudres, B ^a   Bachmann, A ^a   Guerke, L ^a   Mihatsch, M J ^a   Dickenmann, M ^a   Steiger, J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS;

ADULT; ANEMIA; APHTHOUS STOMATITIS; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CYTOPENIA; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LOW DRUG DOSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; CALCINEURIN; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; SIROLIMUS; SWITZERLAND; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870223431     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.07.142     Document Type: Article

References (22)

1. S.M. Flechner, D. goldfarb, K. Solez Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs Transplantation 83 2007 883
2. B.L. Kasiske, C. Guijarro, Z.A. Massy Cardiovascular disease after renal transplantation J Am Soc Nephrol 7 1996 158
3. W.Y. Almawi, D.A. Hess, J.W. Assi Pretreatment with glucocorticoids enhances T-cell effector function: possible implication for immune rebound accompanying glucocorticoid withdrawal Cell Transplant 8 1999 637
4. N.R. Sinclair Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with wellfunctioning grafts The Canadian Multicentre Transplant Study Group CMAJ 147 1992 645
5. A. Rajab, R.P. Pelletier, M.L. Henry Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression Clin Transplant 20 2006 537
6. J.J. Jaber, P.J. Feustel, O. Elbahloul Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirlimus and CellCept-based calcineurin inhibitor-minimization protocol Clin Transplant 21 2007 101
7. M.P. Smith, C.G. Newstead, N. Ahmad Poor tolerance of sirolimus in a steroid avoidance regimen for renal transplantation Transplantation 85 2008 636
8. J.M. Grinyo, J.M. Cruzado Mycophenolate mofetil and sirolimus combination in renal transplantation Am J Transplant 6 2006 199
9. R.L. Heilman, K. Younan, H.M. Wadei Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal Transplantation 92 2011 767
10. M. Buchler, S. Caillard, S. Barbier Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids Am J Transplant 7 2007 2522
11. M.A. Gelens, M.H. Christiaans, E.L. van Heurn High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation Transplantation 82 2006 1221
12. S. Teraoka, S. Sato, M. Sekijima Comparative study of clinical outcome in kidney transplantation between early withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetile and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroid Transplant Proc 37 2005 79
13. Y. Kato, T. Tojimbara, K. Iwadoh Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients Int Immunopharmacol 6 2006 1984
14. M.S. Kumar, M. Heifets, M.L. Moritz Safety and efficacy of steroid withdrawal two days after kidney transplantation: analysis of results at three years Transplantation 81 2006 832
15. J. Pascual, J.P. van Hooff, K. Salmela Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant Transplantation 82 2006 55
16. F. Vincenti, F.P. Schena, S. Paraskevas A randonized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients Am J Transplant 8 2008 307
17. B.J. Nankivell, J.R. Chapman The significance of subclinical rejection and the value of protocol biopsies Am I Transplant 6 2006 2006
18. D. Rush, P. Nickerson, J. Gough Beneficial effects of treatement of early subclinical rejection: a randomized study J Am Soc Nephrol 9 1998 2129
19. H. Kreis, J.M. Cisterne, W. Land Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients Transplantation 69 2000 1252
20. M.R. Weir, S. Mulgaonkar, L. Chan Mycophenolate mofetil-based immunosuppression with sirlimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial Kidney Int 79 2011 897
21. S.M. Flechner, M. Glyda, S. Cockfield The ORION study: con=mparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients Am J Transplant 11 2011 1633
22. F. Vincenti, S. Friman, E. Scheuermann Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus Am J Transplant 7 2007 1506